Raina K, Modak K, Premkumar C, Joshi G, Palani D, Nandy K
Stem Cell Rev Rep. 2025; .
PMID: 39754619
DOI: 10.1007/s12015-024-10836-x.
Nagamura R, Kujirai T, Kato J, Shuto Y, Kusakizako T, Hirano H
Nat Commun. 2024; 15(1):10744.
PMID: 39737984
PMC: 11685650.
DOI: 10.1038/s41467-024-54768-z.
Goldberg G, Kogenaru M, Keegan S, Haase M, Kagermazova L, Arias M
Nat Commun. 2024; 15(1):10287.
PMID: 39604381
PMC: 11603292.
DOI: 10.1038/s41467-024-54629-9.
Schep R, Trauernicht M, Vergara X, Friskes A, Morris B, Gregoricchio S
Nucleic Acids Res. 2024; 52(15):8815-8832.
PMID: 38953163
PMC: 11347147.
DOI: 10.1093/nar/gkae570.
Bergman S, Tuller T
PLoS Comput Biol. 2024; 20(6):e1012214.
PMID: 38848440
PMC: 11189236.
DOI: 10.1371/journal.pcbi.1012214.
How to use CRISPR/Cas9 in plants: from target site selection to DNA repair.
Pribylova A, Fischer L
J Exp Bot. 2024; 75(17):5325-5343.
PMID: 38648173
PMC: 11389839.
DOI: 10.1093/jxb/erae147.
Engineering Cas9: next generation of genomic editors.
Kovalev M, Davletshin A, Karpov D
Appl Microbiol Biotechnol. 2024; 108(1):209.
PMID: 38353732
PMC: 10866799.
DOI: 10.1007/s00253-024-13056-y.
Increasing the Activity of the High-Fidelity SpyCas9 Form in Yeast by Directed Mutagenesis of the PAM-Interacting Domain.
Davletshin A, Matveeva A, Bachurin S, Karpov D, Garbuz D
Int J Mol Sci. 2024; 25(1).
PMID: 38203615
PMC: 10779060.
DOI: 10.3390/ijms25010444.
Engineered transcription-associated Cas9 targeting in eukaryotic cells.
Goldberg G, Kogenaru M, Keegan S, Haase M, Kagermazova L, Arias M
bioRxiv. 2023; .
PMID: 37781609
PMC: 10541143.
DOI: 10.1101/2023.09.18.558319.
Chromatin structure and context-dependent sequence features control prime editing efficiency.
Kim S, Yuan J, Woods W, Newton D, Perez-Pinera P, Song J
Front Genet. 2023; 14:1222112.
PMID: 37456665
PMC: 10344898.
DOI: 10.3389/fgene.2023.1222112.
A qPCR Method to Assay Endonuclease Activity of Cas9-sgRNA Ribonucleoprotein Complexes.
Nguyen M, Kim S, Cheng Y, Hong S, Jin Y, Han N
J Microbiol Biotechnol. 2023; 33(9):1228-1237.
PMID: 37415091
PMC: 10580886.
DOI: 10.4014/jmb.2305.05010.
Chromatin structure and context-dependent sequence features control prime editing efficiency.
Kim S, Yuan J, Woods W, Newton D, Perez-Pinera P, Song J
bioRxiv. 2023; .
PMID: 37162994
PMC: 10168420.
DOI: 10.1101/2023.04.15.536944.
Improving the on-target activity of high-fidelity Cas9 editors by combining rational design and random mutagenesis.
Spasskaya D, Davletshin A, Bachurin S, Tutyaeva V, Garbuz D, Karpov D
Appl Microbiol Biotechnol. 2023; 107(7-8):2385-2401.
PMID: 36917274
DOI: 10.1007/s00253-023-12469-5.
Application of Nicotinamide to Culture Medium Improves the Efficiency of Genome Editing in Hexaploid Wheat.
Wang W, Huang P, Dai W, Tang H, Qiu Y, Chang Y
Int J Mol Sci. 2023; 24(5).
PMID: 36901844
PMC: 10002385.
DOI: 10.3390/ijms24054416.
Novel extragenic genomic safe harbors for precise therapeutic T-cell engineering.
Odak A, Yuan H, Feucht J, Cantu V, Mansilla-Soto J, Kogel F
Blood. 2023; 141(22):2698-2712.
PMID: 36745870
PMC: 10273162.
DOI: 10.1182/blood.2022018924.
The impact of nucleosome structure on CRISPR/Cas9 fidelity.
Handelmann C, Tsompana M, Samudrala R, Buck M
Nucleic Acids Res. 2023; 51(5):2333-2344.
PMID: 36727449
PMC: 10018339.
DOI: 10.1093/nar/gkad021.
Comprehensive computational analysis of epigenetic descriptors affecting CRISPR-Cas9 off-target activity.
Mak J, Stortz F, Minary P
BMC Genomics. 2022; 23(1):805.
PMID: 36474180
PMC: 9724382.
DOI: 10.1186/s12864-022-09012-7.
Decorating chromatin for enhanced genome editing using CRISPR-Cas9.
Chen E, Lin-Shiao E, Trinidad M, Doost M, Colognori D, Doudna J
Proc Natl Acad Sci U S A. 2022; 119(49):e2204259119.
PMID: 36459645
PMC: 9894255.
DOI: 10.1073/pnas.2204259119.
Enzyme-free targeted DNA demethylation using CRISPR-dCas9-based steric hindrance to identify DNA methylation marks causal to altered gene expression.
Sapozhnikov D, Szyf M
Nat Protoc. 2022; 17(12):2840-2881.
PMID: 36207463
DOI: 10.1038/s41596-022-00741-3.
How to Completely Squeeze a Fungus-Advanced Genome Mining Tools for Novel Bioactive Substances.
Schuller A, Studt-Reinhold L, Strauss J
Pharmaceutics. 2022; 14(9).
PMID: 36145585
PMC: 9505985.
DOI: 10.3390/pharmaceutics14091837.